Literature DB >> 1371874

Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay.

D C Wilbur1, J Willis, R A Mooney, M A Fallon, R Moynes, P A di Sant'Agnese.   

Abstract

The steroid receptor (estrogen (ER) and progesterone receptor (PR] status was studied in 94 cases of invasive breast carcinoma from three separate institutions. All cases had fresh tissue examined for ER and PR by the dextran-coated charcoal cytosolic assay (DCC), and each case was examined immunohistochemically for ER and PR from archival formalin-fixed, paraffin-embedded tissue. Immunohistochemical assays (IH) were reviewed blinded to the DCC results and scored in a semiquantitative fashion prior to comparison to the DCC results. Overall, there was agreement between DCC and IH in 89% of ER and in 87% of PR assays. Some 50% of the ER discorrelations were of the IH-positive DCC-negative type, while 27% of the PR discorrelations were of this type. In four cases, both ER and PR did not correlate between IH and DCC determinations, with two being IH (ER and PR) positive and DCC negative, and two of the opposite type. The results of the study show that steroid receptor assays performed on routinely processed formalin-fixed archival material are reliable and closely recapitulate the results of traditional biochemical assays. Results suggest that, in the cases where IH is positive while DCC is negative, the IH result may actually provide a more reliable receptor status of the tumor than does the DCC result. Semiquantitation of fixed tissue IH assays shows a trend toward quantitative correlation with DCC results, but this correlation is weak, and factors concerning fixation and processing are most likely to be responsible.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371874

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female mice.

Authors:  Lucas L Falke; Roel Broekhuizen; Alwin Huitema; Erik Maarseveen; Tri Q Nguyen; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2017-05-11       Impact factor: 5.782

2.  Expression of estrogen receptors in non-malignant mammary tissue modifies the association between insulin-like growth factor 1 and breast cancer risk.

Authors:  E Samoli; A Lagiou; P Zourna; A Barbouni; C Georgila; A Tsikkinis; D Vassilarou; P Minaki; C Sfikas; E Spanos; D Trichopoulos; P Lagiou
Journal:  Ann Oncol       Date:  2014-12-26       Impact factor: 32.976

3.  Oestrogen and progesterone receptor expression in mammary fibromatosis.

Authors:  S A Rasbridge; C E Gillett; R R Millis
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

4.  Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk.

Authors:  Pagona Lagiou; Christina Georgila; Evangelia Samoli; Areti Lagiou; Pantelina Zourna; Ploumitsa Minaki; Dorothy Vassilarou; Ioannis Papadiamandis; Constantinos Sfikas; Victoria Kalapothaki; Constantine E Sekeris; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

5.  Diet and expression of estrogen alpha and progesterone receptors in the normal mammary gland.

Authors:  Pagona Lagiou; Evangelia Samoli; Areti Lagiou; Christina Georgila; Pantelina Zourna; Anastasia Barbouni; George Gkiokas; Dorothy Vassilarou; Annivas Tsikkinis; Constantinos Sfikas; Constantine E Sekeris; Chung-Cheng Hsieh; Hans-Olov Adami; Dimitrios Trichopoulos
Journal:  Cancer Causes Control       Date:  2008-11-27       Impact factor: 2.506

6.  Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.

Authors:  A Pich; E Margaria; L Chiusa; G Candelaresi; O Dal Canton
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

7.  Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

Authors:  D N Poller; D R Snead; E C Roberts; M Galea; J A Bell; A Gilmour; C W Elston; R W Blamey; I O Ellis
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.